StockNews.com cut Oramed Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Satu...
Oramed Pharmaceuticals (NASDAQ:ORMP – Get Free Report) was downgraded by analysts at StockNews.com f...
Investing in stocks inevitably means buying into some companies that perform poorly. But the long te...
NEW YORK (AP) — Oramed Pharmaceuticals Inc. ORMP) on Thursday reported a loss of $7.6 million in its...